Butchertown Clinical Trials News
Olivia Kaiser Promoted to Clinical Trials Site Manager
Olivia Kaiser, who began her career in clinical trials as a subject recruiter and was promoted to Clinical Trials Team Lead, has been promoted to Site Manager at Butchertown Clinical Trials. In Olivia’s new role, she will have expanded planning and trial coordination duties as the site is poised for additional growth and is currently…
Continue Reading Olivia Kaiser Promoted to Clinical Trials Site Manager
You May Benefit By Participating in a Clinical Trial
Our Butchertown Clinical Trials division works with our doctors and patients to test new treatments, or variations of existing treatments, to determine if they are more effective, or safer than existing treatments, and therefore worthy of FDA approval.Under the direction of The Doctors of The Eye Care Institute, our clinical-trials-only staff of almost a dozen…
Continue Reading You May Benefit By Participating in a Clinical Trial
Taking A Weight Loss Drug and Worried About Vision Loss?
A recent study* was published showing an increase in eye disease, for those taking Semaglutide, GLP-1 Antagonist, for weight loss. Two of these three medications, Ozempic and Rybelsus, are FDA-approved for treating Type II Diabetes. These are often used “off-label” for weight loss. Wegovy is FDA-approved for those 12 and over to treat obesity. The…
Continue Reading Taking A Weight Loss Drug and Worried About Vision Loss?
New Clinical Trial – Do you have Demodex Blepharitis and wear Contact Lenses? See below!
Do you ever experience red or itchy eyelids and can’t wear your soft contact lenses as long as you wish? If so, you may qualify for our upcoming research study. Complete our next study and you may be compensated up to $500 for your time. Blepharitis is a common condition that can cause eyelid inflammation…
Butchertown Clinical Trials and The Eye Care Institute Announce 21st FDA Approval
LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for the treatment of ocular inflammation and pain following ocular surgery. Dr. Brennan P. Greene, MD. continued “Although much work remains to eradicate…
Continue Reading Butchertown Clinical Trials and The Eye Care Institute Announce 21st FDA Approval
Butchertown Clinical Trials and The Eye Care Institute Announce Our 19th FDA Approval, XDEMVY™, a novel eyedrop for the treatment of Demodex blepharitis
For Immediate Release – July 25, 2023 Tarsus Pharmaceuticals, Inc, Irvine, CA, announced the U.S. Food and Drug Administration (FDA) has approved XDEMVY (lotilaner ophthalmic solution) 0.25% indicated for the treatment of Demodex blepharitis. XDEMVY is the First and Only FDA-Approved Treatment for Demodex Blepharitis (DB) Tarsus states Demodex blepharitis impacts approximately 25 million eye care patients in the U.S. –…
Tired of wearing reading glasses? Join this upcoming clinical trial
We invite you to join a clinical trial evaluating an investigational eye drop for treating Presbyopia, an age-related condition making it difficult to see things up-close To participate in this study, you must: Be 45-75 years old Have difficulty reading things up close or have Presbyopia You will not qualify if you: Have diabetes, glaucoma,…
Continue Reading Tired of wearing reading glasses? Join this upcoming clinical trial
Do you see well at a distance but have trouble reading up close? You may qualify for a clinical trial! Read below to learn more.
Presbyopia Drop Study Are you having trouble seeing up close? A clinical research study is being conducted for adults who have trouble seeing nearby objects clearly due to presbyopia, or the loss of near vision. You may quality if you are: Between 45 and 80 years old In good general health Not on any eye…
Butchertown Clinical Trials and The Eye Care Institute Announce Our 17th FDA Approval or Clearance
Visant Medical Canalicular Occlusive Device Treating Signs and Symptoms of Dry Eye Disease For Immediate Release Visant Medical, a Menlo Park, CA company, announced FDA Clearance for its patented canalicular occlusive device. The device blocks tear drainage through the canalicular system in patients experiencing both signs and symptoms of dry eye disease for up to…
Butchertown Clinical Trials and The Eye Care Institute Announce Our 16th FDA Approval or Clearance
AEye Health receives FDA clearance for the detection of more than mild to moderate diabetic retinopathy – a first for our clinical trials program For Immediate Release AEye Health, a Tel Aviv biotechnology firm, received FDA clearance for use of the AEYE-DS tool for the detection of more-than-mild diabetic retinopathy with the Topcon NW400 camera…
Diversity, Equity, and Inclusion at The Eye Care Institute, Butchertown Clinical Trials, and the Diversity of Clinical Trials
We believe the unique talents, qualities, and characteristics of our staff and doctors give us the opportunity to reach our goals of improving vision through our routine, medical and surgical eye care services, and improving human health through the services provided by our clinical trials division. We have many training programs, initiatives, and resources to…
Butchertown Clinical Trials Promotes Kellye Johnson to Clinical Trials Site Director
For Immediate Release Louisville, Kentucky January 13, 2022. Butchertown Clinical Trials, an outpatient clinical trials site, today announced the promotion of Kellye Johnson to Clinical Trials Site Director. She will have the overall responsibility for site workflow and resources management. Kellye has been integral to our development during the past five years, and we are…
Butchertown Clinical Trials and The Eye Care Institute Announce Our 15th FDA Approval Vuity™, the first and only eye drop approved for daily correction of near and intermediate vision without affecting distance vision A First for Our Clinical Trials Program Third Approval in Fifteen Days
For Immediate Release Allergan, an AbbVie company announced the U.S. Food and Drug Administration (FDA) has approved VUITY™ (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. Allergan states “VUITY is the first and only FDA-approved eye drop to treat this common and progressive eye condition that…
The Ideal Clinical Trials Research Site
Mark Prussian – CEO Mark M. Prussian is a board-certified healthcare administrator and Chief Executive Officer of The Eye Care Institute. Prussian has served as CEO since 1995 and is responsible for all non-clinical matters at The Eye Care Institute including strategic planning and growth, personnel, training, budgeting, managed care, billing, contracts, purchasing, IT and…
Butchertown Clinical Trials and The Eye Care Institute Announce Our 14th FDA Approval Tyrvaya™, the first and only nasal spray approved for signs and symptoms of Dry Eye Disease – Second Announcement in Two Days
October 19, 2021 For Immediate Release Oyster Point Pharma, a Princeton NJ company, has announced the FDA has approved Tyrvaya™ as the first and only nasal spray approved for treating signs and symptoms of Dry Eye Disease. Guruprasad R. Pattar, MD, PhD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator…
Butchertown Clinical Trials and The Eye Care Institute Announce Our 13th FDA Approval Dextenza®, physician-inserted eye allergy treatment lasting up to 30 days
October 18, 2021 For Immediate Release Ocular Therapeutix, a Bedford MA company, has announced the FDA has approved Dextenza® for treating ocular itching associated with allergic conjunctivitis. John C. Meyer, MD, of The Eye Care Institute and Butchertown Clinical Trials, was a principal investigator for the clinical trials leading to the FDA approval of this…
Health care research facility opens in Butchertown
The Eye Care Institute opened a new research facility on its Butchertown campus. Butchertown Clinical Trials, a division of the Eye Care Institute, announced Friday that the $1.8 million stand-alone clinical trials facility opened at 205 N. Spring Street. It will house eight ongoing clinical trials, according to a news release. Louisville Business First reported in…
Continue Reading Health care research facility opens in Butchertown
Stuart Urbach in Memorium
Stuart Urbach, MD1925 – 2021In Memory Patients, physicians, friends, and co-workers of Dr. Stuart Urbach have lost a giant upon his passing. Dr. Urbach graduated medical school at the University of Louisville in 1947. After completing his internship and residency, he returned to Louisville where he has been associated with the medical school as an…
Coronavirus COVID 19 Clinical Trials
We are a clinical trials center in the Butchertown neighborhood of Louisville, Kentucky. We operate as a division of The Eye Care Institute, which is an extensive ophthalmology practice providing eye surgery, eye care, LASIK, glaucoma laser treatment, dry eye disease care, macular degeneration treatment, and more. Our Butchertown Clinical Trials division employs a family…